(19)
(11) EP 1 165 817 A1

(12)

(43) Date of publication:
02.01.2002 Bulletin 2002/01

(21) Application number: 00920182.3

(22) Date of filing: 06.04.2000
(51) International Patent Classification (IPC)7C12N 15/861, C12N 15/63, A61K 48/00
(86) International application number:
PCT/US0009/149
(87) International publication number:
WO 0060/106 (12.10.2000 Gazette 2000/41)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 06.04.1999 US 286874

(71) Applicant: Merck & Co., Inc.
Rahway, New Jersey 07065-0907 (US)

(72) Inventors:
  • GRAHAM, Frank, L.
    Hamilton, Ontario L8P 2V4 (CA)
  • ANTON, Martina
    Hamilton, Ontario L8S 1A9 (CA)
  • RUDNICKI, Michael, A.
    Dundas, Ontario L9H 4ES (CA)
  • PARKS, Robin
    Ottawa, Ontario K1V 8M6 (CA)

(74) Representative: Perry, Robert Edward 
GILL JENNINGS & EVERY Broadgate House 7 Eldon Street
London EC2M 7LH
London EC2M 7LH (GB)

   


(54) USE OF HELPER-DEPENDENT ADENOVIRAL VECTORS OF ALTERNATIVE SEROTYPES PERMITS REPEAT VECTOR ADMINISTRATION